Relmada Therapeutics, Inc. RLMD Prepaid Insurance
Prepaid Insurance at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidInsurance.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s prepaid insurance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s prepaid insurance?
- Relmada Therapeutics, Inc. (RLMD) reported prepaid insurance of $248.7K in Q1 2026.
- How has Relmada Therapeutics, Inc.'s prepaid insurance changed year-over-year?
- Relmada Therapeutics, Inc.'s prepaid insurance increased by 27.5% year-over-year, from $195K to $248.7K.
- What is the long-term trend for Relmada Therapeutics, Inc.'s prepaid insurance?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s prepaid insurance has grown at a -4.8% compound annual growth rate (CAGR), from $527.6K to $411.9K.
- What does prepaid insurance mean?
- Payments made in advance for insurance coverage that will be recognized as an expense over future periods. This asset represents the unexpired portion of premiums paid for policies such as directors and officers liability or clinical trial insurance. It reflects the company's commitment to risk management and operational continuity.